Introduction
Mast cells play a pivotal role in the development of IgEmediated allergic reactions through releasing stored and newly synthesized inflammatory mediators following crosslinking of the high-affinity IgE receptor (FcεRI) on the cell surface (1) . FcεRI belongs to a family of multi-subunit hematopoietic cell receptors, including the TCR and B cell antigen receptor (BCR). All the members of this family lack an intrinsic protein tyrosine kinase (PTK) activity, but possess cytoplasmic component-containing immunoreceptor tyrosine-based activation motifs for initiating the phosphorylation-mediated signaling cascade (2, 3) . In the signaling pathway from these immunoreceptors to the nucleus, PTKs belonging to the Src, Syk/Zap70 and Btk/Tec families are activated, and in turn they phosphorylate other cellular enzymes as well as adaptor or linker proteins lacking catalytic activities.
Recently much attention has been focused on a critical role intracellular signaling pathways downstream of TCR and BCR respectively. In a SLP-76-deficient Jurkat T cell line, increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and activation of the Ras pathway following TCR cross-linking were severely impaired (11) . Moreover, a profound block in thymocyte development in SLP-76-deficient mice indicated an essential role of SLP-76 for pre-TCR signaling (12, 13) . On the other hand, a BLNK-deficient DT40 cell line displayed severe defects in tyrosine phosphorylation of PLCγ, [Ca 2ϩ ] i increase and c-Jun N-terminal kinase activation following BCR stimulation (14) . Given the close similarities of the signaling pathways transduced from FcεRI and BCR/TCR, we speculated that BASH/ SLP-76-related adaptor proteins may be involved in FcεRI signaling in mast cells. By the homology search in a database and the following cDNA cloning, we have identified the third member of the BASH/SLP-76 family expressed in mast cells, termed MIST (mast cell immunoreceptor signal transducer), which has later been found to be identical to a recently reported cytokine-dependent hemopoietic cell linker, Clnk (15) . Here we show that MIST/Clnk functions as a crucial adaptor molecule in the FcεRI signaling pathway leading to mast cell degranulation.
Methods

Mast cells
Mouse bone marrow-derived mast cells (BMMC) were prepared by culturing bone marrow cells from C57BL/6 mice in RPMI 1640 medium supplemented with 10% FCS and 10 ng/ ml of mouse IL-3 (Peprotech, London, UK), as described (16) . Human cord blood-derived mast cells (HCMC) were raised as described by Yanagida et al. (17) , and cultured in α-MEM supplemented with 12.5% FCS and recombinant human stem cell factor and IL-6 (Peprotech) for at least 10 weeks to obtain a Ͼ99% pure mast cell population. RBL-2H3 cells, which were obtained from the Riken Cell Bank, and an IL-3-independent variant of PT-18 mouse mast cell line were also used for the study.
cDNA cloning and expression constructs
The mouse MIST cDNA was isolated from a PT18 cDNA library by 5Ј-and 3Ј-RACE (Marathon cDNA amplification kit; Clontech, Palo Alto, CA), using the sequence information from the unidentified expressed sequence tag (EST) cDNA clone (GenBank accession no. AA166259) that had been found to show a homology to BASH. The partial human MIST cDNA was also amplified by PCR from mRNA prepared from HCMC using oligonucleotide primers: 5Ј-GTGATGATGACTATGATG-ACCCTGAGCTTC-3Ј and 5Ј-GGGAAAATTCTTGTAGTGTTC-GATGATGTC-3Ј. The coding region of mouse MIST cDNA was amplified by PCR, and then inserted between the EcoRI and SalI sites of the pCAT7neo expression vector (6) . The MIST mutant (MIST-YF) containing phenylalanine for tyrosine substitutions at positions 69, 96, 101, 153, 174 and 188 was generated by sequential PCR-based mutagenesis using a Quickchange site-directed mutagenesis kit (Stratagene, La Jolla, CA), and then subcloned into the pCAT7neo expression vector.
Antibodies
Rabbit anti-MIST antibody was generated by immunization with a fusion protein composed of amino acids 193-435 of mouse MIST and glutathione-S-transferase (GST). Antisera were precleared with Sepharose beads coupled with GST alone and then purified with an affinity column coupled with GST-MIST fusion protein. Specificity of the affinity-purified antibody was confirmed by immunoblot analysis on cell lysates from COS7 cells transfected with mouse MIST cDNA. Other antibodies used were anti-PLCγ2 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-Vav (Upstate Biotechnology, Lake Placid, NY), anti-Grb2 (Santa Cruz Biotechnology), antilinker for activation of T cells (LAT) (Upstate Biotechnology), anti-T7 antibody (Novagen, Madison, WI) and PY20 (Transduction Laboratories, Lexington, KY).
Northern blot, RT-PCR and immunohistochemistry
Total RNA (10 µg) was separated in a denaturing agarose gel, as described previously (6) . After blotting, hybridization was performed with either mouse MIST, a full-length mouse BASH or mouse SLP-76 cDNA probes (provided from Dr H. Gu). A mouse β-actin cDNA probe was also used to normalize the amount of RNA loaded in each lane. For RT-PCR, 2 µg total RNA was reverse-transcribed using an oligo(dT) primer and 1/20th of the resultant cDNA was subjected to PCR amplification. Oligonucleotide primers used were 5Ј-TATGAC-CAGCCAGGGCAATAAAAGGACAAC-3Ј and 5Ј-CTTACTCA-TGAAGTGCCTGGCTGGAGTAC-3Ј for mouse MIST, and primers described above for human MIST cDNA respectively. Normalization was done using primers specific for G3PDH mRNA. The PCR was carried out as follows: 30 cycles of 94°C, 30 s and 68°C, 2 min. The tyramid-based signal amplification method (NEN Life Science, Boston, MA) was used for immunohistochemical analysis. Frozen sections of skin were first incubated with the affinity-purified anti-MIST antibody, rinsed and incubated with horseradish peroxidase (HRP)-labeled anti-rabbit IgG antibody, then with biotinylated tyramid. The reactions were developed by streptavidin-HRP and 3-amino-9-ethylcarbazole. The serial sections were also stained with toluidine blue (pH 4.0) for detecting mast cells.
Immunoprecipitation and immunoblotting
RBL-2H3 cells were transfected by electroporation with either pCAT7neo-MIST-WT, MIST-YF or empty vector and selected in medium containing Geneticin (Gibco, Grand Island, NY) at 1 mg/ml. Stable expression of the transfected MIST was verified by Western blotting with anti-T7 antibody. These clones were incubated with 10 µg/ml of anti-DNP mouse IgE (Sigma, St Louis, MO) for 1 h on ice and then stimulated with 100 ng/ml of DNP-HSA at 37°C for the indicated period of time. Cells were lysed with 1% NP-40 lysis buffer containing protease and phosphatase inhibitors, and immunoprecipitated with indicated antibodies. The immunoprecipitates and aliquots of total cell lysates were resolved on SDS-PAGE and transferred to PVDF membranes. The membranes were immunoblotted with antibodies described above and the secondary antibodies conjugated with HRP, and then developed with the ECL system (Amersham, Arlington Heights, IL). COS7 cells were co-transfected with 1 µg of pCAT7neo-MIST with the indicated combination of 1 µg of pME-Lyn, pME-Syk, or pEF-BOS-Btk plasmids (18,19) using a TransIT-LT1 transfection reagent (Pan Vera, Madison, WI). After incubation for 48 h, cell lysates were prepared and analyzed for tyrosine phosphorylation described above.
Degranulation assay
RBL-2H3 cells (2ϫ10 5 cells in 0.4 ml, 24-well plates) stably transfected with a mock vector or with a vector encoding MIST-WT or MIST-YF were sensitized overnight with 1 µg/ml of DNP-specific IgE. Cells were subsequently washed twice with PBS and stimulated with various amounts of DNP-HSA at 37°C for 30 min. Degranulation was monitored by the release of β-hexosaminidase, as previously described (16) . Percent degranulation was calculated as activity in the culture medium/activity in the culture medium ϩ activity in the cell lysate.
Measurement of [Ca 2ϩ ] i concentration
RBL-2H3 cells (5ϫ10 6 ) expressing MIST-WT and MIST-YF were loaded with 5 µM Fura-2/AM (Molecular Probes, Eugene, OR) in the presence of 10 µg/ml of DNP-specific IgE at 37°C for 30 min, washed twice with Tyrode buffer containing 0.1% BSA and then stimulated with 100 ng/ml of DNP-HSA or ionomycin (1 µM) at 37°C. [Ca 2ϩ ] i was monitored at a 510 nm emission wavelength excited by 340 and 360 nm using a fluorescence spectrophotometer (F-4500; Hitachi, Tokyo, Japan) (16) .
Luciferase assay
RBL-2H3 cell clones were transiently transfected with 10 µg of a luciferase reporter plasmid driven by seven tandem copies of the NF-AT response element from the mouse IL-2 gene promoter (a gift from Dr K. Arai) in serum-free RPMI at a density of 6ϫ10 6 cells/400 µl per cuvette with a gene pulser (BioRad, Hercules, CA) set at 250 V and 975 µF. After electroporation, the cells were transferred to complete RPMI and incubated at 37°C for 24 h. Cells (2ϫ10 6 ) were then sensitized overnight with 1 µg/ml of DNP-specific IgE and then either left unstimulated or stimulated with DNP-HSA (50 ng/ml) or phorbol myristate acetate (50 ng/ml) plus ionomycin (1 µM) for 6 h. Luciferase activity was monitored, as described previously (6) .
Results
Identification of a BASH/SLP-76-related molecule expressed in mast cells
By screening the EST database, we identified a cDNA clone from a 13.5-day-old mouse embryo cDNA library (GenBank accession no. AA166259) that exhibited significant amino acid homology to the SH2 domain of chicken BASH. By Northern blot analysis, mRNA corresponding to this clone was undetectable in adult bone marrow, spleen, lymph nodes, thymus, lung and brain (data not shown). Further analysis, however, revealed that a 1.8 kb mRNA corresponding to this clone was expressed in a mastocytoma line, P815, but not in any other hematopoietic or non-hematopoietic lineage cell lines representative of B cells, T cells and macrophages (Fig. 1A). Because of its expression pattern and function (described below), we have named this molecule MIST. After isolation of a full-length mouse MIST cDNA and a partial human MIST cDNA, we further examined the expression of MIST mRNA by RT-PCR in IL-3-induced BMMC and HCMC. MIST transcripts were readily detected in these two normal mast cell cultures (Fig. 1B) . MIST were also weakly expressed in other mouse mast cell line PT18 and rat mast cell line RBL-2H3, To examine expression of MIST protein, we raised a rabbit serum against mouse MIST. The affinity-purified antibody recognized a 60 kDa protein in BMMC as well as in COS7 cells transfected with the mouse MIST cDNA (data not shown). Using the anti-MIST antibody, we stained serial sections of skin from NC/Nga mice, which spontaneously develop atopic dermatitis-like lesions (20) , to clarify the cell populations expressing MIST in situ. Remarkably, the mast cells infiltrating the skin of NC/Nga mice, which were detected by toluidine blue staining (Fig. 1C) , were the only cells that expressed MIST protein in the lesions (Fig. 1D) . Furthermore, mast cells in normal skin also express MIST protein, as determined by immunohistochemistry (data not shown).
MIST is a novel member of the BASH/SLP-76 adaptor protein family
The mouse MIST cDNA is predicted to encode a 435 amino acid protein, with a calculated mol. wt of 49 kDa (Fig. 2) . From the N-terminus to the central region of the molecule, MIST protein contains eight tyrosine residues at amino acid positions 69, 96, 101, 153, 174, 188, 249 and 286, all of which display consensus motifs that could mediate the interaction with other proteins containing an SH2 domain (21, 22) . The C-terminal part of the protein contains an SH2 domain that is most homologous to that of mouse SLP-76 and BASH/SLP-65/BLNK (41 and 38% identity respectively). The central region of the protein is rich in prolines and contains one potential Grb2 SH3 domain-binding sequence (PXXPXR) (23) . Comparison of a partial human MIST sequence with mouse MIST revealed that five tyrosine residues are conserved between species, two of which are also found in SLP-76 and BASH/SLP-65/BLNK. Human MIST has one additional PXXPXR SH3-binding motif between amino acid positions 246 and 251 (Fig. 2) . During the analysis of RT-PCR products of MIST mRNA, potential alternatively spliced variants of mouse and human MIST were also identified. The shorter form of mouse MIST lacks 24 amino acids (amino acid positions from 5 to 28) located proximal to N-terminus of the protein, while 37 amino acids (amino acid positions from 147 to 183) in the proline-rich region are missing in the shorter form of human MIST. MIST does not contain a stretch of acidic or basic amino acid residues in its N-terminus, but apart from that the overall structure of MIST is very similar to that of BASH/SLP-65/BLNK and SLP-76. We thus concluded that MIST is a third member of the BASH/SLP-76 adaptor family.
During the submission of this manuscript, a sequence identical to the mouse MIST was reported as a cytokinedependent hemopoietic cell linker (Clnk) (15) . Mouse Clnk mRNA was reported to be detected not only in IL-3-induced BMMC but also in IL-2-activated T and NK cells or IL-2/3-dependent cell lines. Clnk mRNA was also detected in a few cytokine-independent cell lines, including a mastocytoma cell line P815, as we have shown above. A possibility of constitutive expression of MIST/Clnk is discussed below (see Discussion).
MIST/Clnk functions as an adaptor protein in FcεRI signaling
We next examined whether MIST/Clnk is a substrate of FcεRI-associated PTK. For this purpose, we used a rat mast cell line, RBL-2H3, which has been extensively studied for FcεRI-signaling. Expression vectors encoding a wild-type (MIST-WT) or a mutant (MIST-YF; see below) form of mouse MIST tagged with the T7 epitope at the N-terminus were transfected into RBL-2H3 cells. Clones stably expressing high levels of MIST proteins were established and the cloned cells were sensitized with anti-DNP-IgE, followed by challenge with DNP-HSA. MIST was tyrosine phosphorylated even before stimulation, and the level of phosphorylation rapidly increased as early as 10 s and reached a maximum at 30 s after the FcεRI cross-linking (Fig. 3A) . In addition, several tyrosine phosphorylated proteins were co-precipitated with MIST, including a 55 kDa unidentified phosphoprotein (Fig. 3A) . By using a panel of antibodies against known PTK substrates, we identified the association of MIST with PLCγ2 and Vav (Fig  3 B) . Grb2 was also found to be co-precipitated with MIST. By contrast, MIST-YF, which has phenylalanines substituted for tyrosines at positions 69, 96, 101, 153, 174 and 188, failed to be tyrosine phosphorylated after FcεRI cross-linking. MIST-YF was also unable to associate with PLCγ2 and Vav, but still retained the ability to associate with Grb2. The reciprocal experiment using anti-Vav, anti-PLCγ2 and anti-Grb2 antibodies for immunoprecipitation confirmed these results (data not shown). These data suggest that MIST/Clnk functions as a crucial adaptor protein downstream of FcεRI, in a manner similar to the function of BASH/SLP-65/BLNK and SLP-76 in BCR and TCR signalings.
To identify PTK responsible for the phosphorylation of MIST/ Clnk, COS7 cells were co-transfected with expression vectors encoding MIST and Lyn, Syk and Btk. Co-expression of Lyn with or without the other kinases induced significant tyrosine phosphorylation of MIST (Fig. 3C) . In contrast, co-expression of either Syk or Btk, alone or together, did not induce tyrosine phosphorylation of MIST/Clnk. This suggests that Lyn is primarily responsible for the observed phosphorylation, although the possibility of Syk-and Btk-mediated phosphorylation of MIST/Clnk in mast cells cannot be excluded. This Lyn-mediated phosphorylation of MIST appears to differ from the observation that BASH/SLP-65/BLNK and SLP-76 are substrates for Syk/Zap-70, but not for Lyn kinase, in B cells and T cells, respectively (5-7).
Overexpression of a mutant form of MIST/Clnk abolished FcεRI-mediated mast cell degranulation
We next examined whether MIST/Clnk is functionally involved in FcεRI-mediated degranulation using the RBL-2H3 cell stable transfectants. Although overexpression of wild-type MIST had no effect on FcεRI-induced degranulation, overexpression of MIST-YF significantly suppressed this response (Fig.  4A) . Overexpression of either MIST-WT and MIST-YF did not affect degranulation response induced by ionomycin, which by-pass the receptor-proximal signal activation (data not shown). Since elevation in [Ca 2ϩ ] i is believed to be required for the mast cell degranulation response, we examined [Ca 2ϩ ] i increase, NF-AT transcriptional activation and phosphorylation of signaling molecules involved in the [Ca 2ϩ ] i increase. Upon FcεRI cross-linking, [Ca 2ϩ ] i increase in RBL-2H3 clones expressing MIST-YF was diminished to almost half the level of that in clones expressing MIST-WT (Fig. 4B) . Furthermore, the FcεRI-mediated NF-AT activation, which is believed to be dependent on both Ras and calcium pathways (24) , was substantially reduced in a MIST-YF-expressing clone, as compared with a mock-transfected clone (Fig. 4C) . However, there was no significant difference in tyrosine phosphorylation of PLCγ2, Vav (Fig. 4D ) and PLCγ1 (data not shown). In the clones expressing MIST-YF, we observed reduced tyrosine phosphorylation of LAT, which is a critical linker molecule in TCR signaling (25) (26) (27) . LAT was found to associate with MIST-WT, but not with MIST-YF (Fig. 4D ). Although the mechanism by which the mutant form of MIST interferes with tyrosine phosphorylation of LAT remains unclear, it is likely that MIST is situated upstream of LAT in the FcεRI signaling pathway and regulates the interaction of Syk with its potential substrate, LAT (26) .
Discussion
The data presented here indicated that MIST/Clnk is structurally and functionally similar to BASH and SLP-76 adaptor proteins, and functions as a crucial signaling component for FcεRI-mediated mast cell degranulation. Overexpression of a mutant form of MIST (MIST-YF) in RBL-2H3 cells severely inhibited FcεRI-mediated mast cell degranulation, [Ca 2ϩ ] i increase, NF-AT-activation and LAT tyrosine phosphorylation. This mutant MIST presumably acts as a dominant negative form by competing with the endogenous MIST/Clnk for interaction with other signaling molecules via proline-rich or SH2 domains. Thus, MIST/Clnk is likely to link the FcεRI and the associated PTK to the downstream signaling molecules by physical interactions.
The observed calcium defect in MIST-YF-expressing RBL cell clones is most likely due to reduced activity of PLCγ, although the tyrosine phosphorylation of PLCγ appears unaffected. Several lines of evidence support the notion that net tyrosine phosphorylation of PLCγ may not correctly reflect the functional activation of PLCγ (28, 29) . PLCγ is primarily phosphorylated by Syk, but additional phosphorylation by Btk is believed to be required for full activation of PLCγ (30) , although no definitive evidence has been provided in the context of FcεRI signaling in mast cells. For activation of Btk, membrane targeting of Btk through interaction of its PH domain and phosphatidylinositol-3,4,5-triphosphate generated by phosphatidylinositol-3-kinase appears to be necessary (31) . Thus, one possible mechanism by which a mutant form of MIST suppresses FcεRI-mediated [Ca 2ϩ ] i increase could be an interference with the activation or function of either phosphatidylinositol-3-kinase or Btk, in which an endogenous MIST is involved. In this regard, tyrosine-phosphorylated BASH/SLP-65/BLNK, a B cell analogue of MIST/Clnk, was recently reported to bind to the SH2 domain of Btk and to facilitate Btk to target PLCγ as a substrate (32) , suggesting a possible interplay between MIST/Clnk, Btk and PLCγ.
Alternatively, the reduced tyrosine phosphorylation of LAT caused by overexpression of a dominant negative MIST may imply that MIST/Clnk is involved in LAT-mediated assembly of signaling molecules including PLCγ at a detergent-resistant membrane raft, which is a specialized membrane domain serving as the center for receptor-mediated activation (33) . The apparent discrepancy between impaired calcium elevation and preserved PLCγ2 tyrosine phosphorylation in MIST-YF-expressing RBL-2H3 cells might be partly ascribed to the potential lack of PLCγ2-LAT assembly, because the raft is enriched with PLCγ substrate, phosphatidylinositol-4,5-biphosphate (34) . Furthermore, it has been noted that mast cells from LAT-deficient mice display an impaired FcεRI-mediated degranulation (35) . Therefore, it is possible to think that MIST/Clnk may bring LAT in the vicinity of Syk to allow it to be phosphorylated and to potentiate it to be a scaffold protein which brings together the signaling proteins essential for degranulation.
SLP-76, a structural relative of MIST/Clnk, has been reported to be expressed in mast cells and be tyrosine phosphorylated upon the FcεRI engagement in RBL-2H3 cells (36) . Because both MIST/Clnk and SLP-76 can associate with a similar set of signaling proteins, including PLCγ, Vav and Grb2 (4,9,10), the observed tyrosine phosphorylation of PLCγ in MIST-YFexpressing clones may be mediated by SLP-76. Similar to the MIST-YF-expressing RBL-2H3 cell clones we described here, FcεRI-mediated degranulation and cytokine production of BMMC from SLP-76-deficient mice were almost completely abrogated, whereas phosphorylation of PLCγ and Vav and the [Ca 2ϩ ] i response were not drastically reduced (37) . We could not detect the significant MIST/Clnk expression in cells except for mast cells in allergic skin from NC/Nga mice. This might be due to the fact that local concentration of cytokines at the allergic sites is not high enough to induce MIST/Clnk expression in T or NK cells, compared to the in vitro experimental conditions described by Cao et al. (15) . Thus, the cytokine-induced expression of MIST/Clnk in vivo remains to be tested.
If the expression of MIST/Clnk is up-regulated by cytokines in vivo, it would be feasible that, at sites of allergic reaction, MIST/Clnk mediates the cross-talk between the signals from FcεRI and cytokine receptors: cytokines released by T cells and also by mast cells themselves will up-regulate expression of MIST/Clnk in mast cells, which may in turn render FcεRI hypersensitive to the antigen-IgE complex. As such, MIST/ Clnk may be an ideal target for potential therapeutic intervention in allergy and mast cell malignancies.
